title: Monitoring adherence to HIV therapy.
authors.forename: A
authors.initials: A
authors.lastname: Tuldrà
authors.forename: M J
authors.initials: MJ
authors.lastname: Ferrer
authors.forename: C R
authors.initials: CR
authors.lastname: Fumaz
authors.forename: R
authors.initials: R
authors.lastname: Bayés
authors.forename: R
authors.initials: R
authors.lastname: Paredes
authors.forename: D M
authors.initials: DM
authors.lastname: Burger
authors.forename: B
authors.initials: B
authors.lastname: Clotet
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood; D003430:Cross-Sectional Studies; D004351:Drug Resistance; D005260:Female; D015658:HIV Infections / Q000097:blood* / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood; D006801:Humans; D016014:Linear Models; D008297:Male; D010349:Patient Compliance; D012646:Self Administration
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors